Design and Rationale of the ERA-CVD Consortium PREMED-CAD—Precision Medicine in Coronary Artery Disease
Open Access
- 10 January 2020
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 10 (1), 125
- https://doi.org/10.3390/biom10010125
Abstract
Cardiovascular diseases (CVDs) comprise 45% of all deaths in Europe and causes 3.9 million deaths annually. Coronary artery disease (CAD) which includes myocardial infarction (MI) represents the most common form of CVD. A relevant proportion of MI cases seems preventable since reports claim that up to two-thirds of these patients exhibit symptoms suggestive for MI within 12 months prior to the acute MI event. An early identification of these at-risk subjects is necessary to manage an early and efficient treatment during the ischemic phase. The aim of the PRecision MEDicine in Coronary Artery Disease (PREMED-CAD) consortium is to apply a system medicine approach towards studying and identifying an ischemia specific ‘biomarker signature’ that improves the identification of individuals ‘at-risk’ for acute MI. The consortium will take an interdisciplinary and translational approach integrating knowledge from CAD epidemiology, imaging, bioinformatics, statistics and molecular biology, as well as existing phenotypic, blood-based and clinical biomarker data of distinct CAD and subclinical MI phenotypes. This biomarker signature will be validated through atherosclerosis-prone mouse models and human cohorts. The validated signature will be translated in a real-world clinical setting using an ongoing clinical trial comprising patients with subclinical ischemia. The aim of the knowledge obtained from this project is to aid in early MI detection and reduce the mortality and morbidity rate in these at-risk MI individuals.This publication has 13 references indexed in Scilit:
- Adaptive penalization in high-dimensional regression and classification with external covariates using variational BayesBiostatistics, 2021
- High-Dimensional Multi-Block Analysis of Factors Associated with Thrombin Generation PotentialPublished by Institute of Electrical and Electronics Engineers (IEEE) ,2019
- DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assaysBioinformatics, 2019
- Generalized Additive Models for Large Data SetsJournal of the Royal Statistical Society Series C: Applied Statistics, 2014
- Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities StudyCirculation, 2011
- Low Diagnostic Yield of Elective Coronary AngiographyThe New England Journal of Medicine, 2010
- C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysisThe Lancet, 2010
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008
- B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart FailureCirculation, 2002
- High-Sensitivity C-Reactive ProteinCirculation, 2001